Department of Psychosomatic Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.
Division of Palliative Care, Department of Medicine, Konan Medical Center, Kobe, Japan.
Jpn J Clin Oncol. 2022 Mar 3;52(3):260-265. doi: 10.1093/jjco/hyab193.
Dyspnea is a common and distressing symptom in patients with cancer. To improve its management, multicenter confirmatory studies are necessary. Research policy would be useful in conducting these studies. Here, we propose a new research policy for the management of dyspnea in patients with cancer.
The first draft was developed by a policy working group of 11 specialists in the field of supportive care or palliative care for dyspnea. Then, a provisional draft was developed after review by a research support group (the Japanese Supportive, Palliative and Psychosocial Care Study Group) and five Japanese scientific societies (Japanese Association of Supportive Care in Cancer, Japanese Society of Medical Oncology, Japanese Society of Palliative Medicine, Japanese Association of Rehabilitation Medicine and Japanese Society of Clinical Oncology), and receipt of public comments.
The policy includes the following components of research policy on dyspnea: (i) definition of dyspnea, (ii) scale for assessment of dyspnea, (iii) reason for dyspnea or factors associated with dyspnea and (iv) treatment effectiveness outcomes/adverse events. The final policy (Ver1.0) was completed on 1 March 2021.
This policy could help researchers plan and conduct studies on the management of cancer dyspnea.
呼吸困难是癌症患者常见且令人痛苦的症状。为了改善其管理,有必要进行多中心确证性研究。研究政策在开展这些研究方面将是有用的。在这里,我们提出了一种新的癌症患者呼吸困难管理研究政策。
政策工作组由 11 名支持性护理或姑息治疗呼吸困难领域的专家制定了第一份草案。然后,在研究支持小组(日本支持性、姑息性和心理社会护理研究小组)和五个日本科学协会(日本癌症支持护理协会、日本肿瘤学会、日本姑息医学学会、日本康复医学协会和日本临床肿瘤学会)审查后制定了临时草案,并收到了公众的意见。
该政策包括呼吸困难研究政策的以下组成部分:(i)呼吸困难的定义,(ii)呼吸困难评估量表,(iii)呼吸困难的原因或与呼吸困难相关的因素,以及(iv)治疗效果结果/不良事件。最终政策(版本 1.0)于 2021 年 3 月 1 日完成。
该政策可以帮助研究人员计划和开展癌症呼吸困难管理的研究。